Ovarium Cancer Detection by TEP's and ctDNA
Early Detection of Ovarian Cancer and Treatment Response by Tumor Educated Platelets (TEP's) and Circulating Tumor DNA (ctDNA)
Sponsor: Amsterdam UMC, location VUmc
A observational or N/A phase clinical study on Ovarian Neoplasms, this trial is ongoing. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 8 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
May 2022 — Jan 2024 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Recruiting
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- Catharina Ziekenhuis Eindhoven
- Gynaecologisch Oncologisch Centrum Zuid
- Leiden University Medical Center
- The Netherlands Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .